Literature DB >> 21670982

The importance of testing PET-directed therapy in patients with Hodgkin lymphoma.

James O Armitage1.   

Abstract

Measuring the rapidity of response by PET scan and changing the treatment regimen in slow responders may lead to an improved outcome. Ongoing studies addressing this possibility have the potential to answer this question and need to be supported.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21670982     DOI： 10.1007/s11899-011-0092-z

Source DB:  PubMed          Journal:  Curr Hematol Malig Rep        ISSN： 1558-8211            Impact factor:   3.952


  5 in total

1.  The radical radiotherapy of regionally localized Hodgkin's disease.

Authors:  H S KAPLAN
Journal:  Radiology       Date:  1962-04       Impact factor: 11.105

2.  A study of Hodgkin's disease treated by irradiation.

Authors:  M V PETERS; K C MIDDLEMISS
Journal:  Am J Roentgenol Radium Ther Nucl Med       Date:  1958-01

Review 3.  Early-stage Hodgkin's lymphoma.

Authors:  James O Armitage
Journal:  N Engl J Med       Date:  2010-08-12       Impact factor: 91.245

4.  Combination chemotherapy in the treatment of advanced Hodgkin's disease.

Authors:  V T Devita; A A Serpick; P P Carbone
Journal:  Ann Intern Med       Date:  1970-12       Impact factor: 25.391

5.  Prognostic significance of mid- and post-ABVD PET imaging in Hodgkin's lymphoma: the importance of involved-field radiotherapy.

Authors:  D J Sher; P M Mauch; A Van Den Abbeele; A S LaCasce; J Czerminski; A K Ng
Journal:  Ann Oncol       Date:  2009-06-18       Impact factor: 32.976
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.